← Back to Search

Dietary Supplement

Beet for Inflammation

N/A
Waitlist Available
Led By David C Nieman, DrPH
Research Sponsored by Appalachian State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exercise
Awards & highlights

Study Summary

This trial tests if a beet-based supplement can reduce exercise-related inflammation over 2 weeks.

Eligible Conditions
  • Inflammation
  • Metabolic Disorders
  • Immunosuppression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, 3 hours-, and 24 hours-post-exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Plasma lipid mediators
Secondary outcome measures
Plasma nitrate and nitrite concentrations
Plasma proteins

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BeetExperimental Treatment1 Intervention
Powdered beets with green tea extract, Camu Camu, Quinoa sprouts, 3 mushroom blend.
Group II: PlaceboPlacebo Group1 Intervention
Similar colored powder with no active ingredients.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Beet
2023
N/A
~30

Find a Location

Who is running the clinical trial?

Appalachian State UniversityLead Sponsor
40 Previous Clinical Trials
2,172 Total Patients Enrolled
12 Trials studying Inflammation
471 Patients Enrolled for Inflammation
Standard ProcessUNKNOWN
David C Nieman, DrPHPrincipal InvestigatorAppalachian State Univ
13 Previous Clinical Trials
635 Total Patients Enrolled
4 Trials studying Inflammation
188 Patients Enrolled for Inflammation

Media Library

Beet (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05907135 — N/A
Inflammation Research Study Groups: Beet, Placebo
Inflammation Clinical Trial 2023: Beet Highlights & Side Effects. Trial Name: NCT05907135 — N/A
Beet (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05907135 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any prerequisites for participation in this research endeavor?

"For this clinical trial, patients must display signs of inflammation and range in age from eighteen to sixty. There are currently 25 available slots for patient enrolment."

Answered by AI

Are there any open enrollment slots for this investigation yet?

"Affirmative. According to clinicaltrials.gov, this medical trial is currently recruiting participants with the original posting date of July 1st 2023 and recent updates on June 8th 2023. A total of 25 patients need to be recruited from a single site."

Answered by AI

Is this research trial open to participants who are aged 35 or older?

"Patients must be between 18 to 60 years of age in order to meet the requirements for this medical trial. Furthermore, there are 35 clinical trials tailored specifically towards children and 315 trial sites catering exclusively for those over 65."

Answered by AI

What is the scope of enrolment for this experiment?

"Affirmative, the info contained on clinicaltrials.gov reveals that this medical trial is currently enlisting volunteers. The research project was first posted on July 1st 2023 and recently updated on June 8th 2023. A total of 25 individuals are sought from a single site for participation in the study."

Answered by AI
~14 spots leftby Apr 2025